Christopher Rayner

University of Adelaide

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Tongzhi Wu

University of Adelaide

AUSTRALIA

View details

Maryam Hajishafiee

AUSTRALIA

View details

Nicolai J. Wewer Albrechtsen

DENMARK

View details

Christine Bryant

UNITED STATES

View details

Carolyn Deacon

Københavns Universitet

DENMARK

View details

Christine Feinle-Bisset

University of Adelaide

AUSTRALIA

View details

Michael Horowitz

University of Adelaide

AUSTRALIA

View details

Karen Jones

University of South Australia

AUSTRALIA

View details

Weikun Huang

University of Adelaide

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Rayner

Research Interests

Explore related searches

Contact this professor

Articles (10)

Effect of gastric distension with concurrent small intestinal saline or glucose infusion on incretin hormone secretion in healthy individuals: A randomized, controlled, crossover study

Editorial: empirical pharmacological management of gastroparesis—a cautionary tale

First‐in‐human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations

Cholecystectomy is associated with dysglycaemia: Cross‐sectional and prospective analyses

Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2‐hour plasma glucose in individuals without diabetes

Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509–2518

Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes

Spontaneous or Deliberate: Effects of Acute Variations in Glycemia on Gastric Emptying in Type 1 Diabetes

Gastrointestinal adverse events with insulin glargine/lixisenatide fixed‐ratio combination versus glucagon‐like peptide‐1 receptor agonists in people with type 2 diabetes mellitus: A network meta‐analysis

Collaborators (9)

Tongzhi Wu

Maryam Hajishafiee

Nicolai J. Wewer Albrechtsen

Christine Bryant

Carolyn Deacon

Christine Feinle-Bisset

Michael Horowitz

Karen Jones

Weikun Huang

Make your next move.